| Year |
Citation |
Score |
| 2019 |
Rose TL, Hayward MC, Salazar AH, Eulitt P, McGinty K, Drier A, Wobker SE, Whang YE, Brower BY, Dunn M, Crona DJ, Shibata Y, Uronis JM, Mayhew G, Milowsky MI, et al. Fibroblast growth factor receptor status and response to immune checkpoint inhibition in metastatic urothelial cancer. Journal of Clinical Oncology. 37: 458-458. DOI: 10.1200/Jco.2019.37.7_Suppl.458 |
0.368 |
|
| 2019 |
Crona DJ, Drier A, Zhu JD, Bell EF, Sketch MR, Garrett A, Mitchell K, Tomlins SA, Dees EC, Godley PA, Dunn M, Rose TL, Basch EM, Milowsky MI, Whang YE. Next generation sequencing of primary prostate cancer tumors to reveal potentially actionable opportunities for clinical management: The UNC experience. Journal of Clinical Oncology. 37: 305-305. DOI: 10.1200/Jco.2019.37.7_Suppl.305 |
0.417 |
|
| 2019 |
Crona DJ, Drier A, Zhu JD, Bell EF, Sketch MR, Boland A, Garrett A, Wang L, Mitchell K, Tomlins SA, Dees EC, Godley PA, Dunn M, Rose TL, Basch EM, et al. Next-generation sequencing of primary prostate cancer tumors to reveal actionable opportunities for clinical management. Journal of Clinical Oncology. 37: e16582-e16582. DOI: 10.1200/Jco.2019.37.15_Suppl.E16582 |
0.457 |
|
| 2015 |
Rose TL, Deal AM, Basch EM, Godley PA, Rathmell K, Kim WY, Whang YE, Dunn M, Nielsen ME, Pruthi R, Wallen E, Woods M, Smith A, Milowsky MI. Effectiveness of chemotherapy administration and time to cystectomy following neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) in the academic and community settings. Journal of Clinical Oncology. 33: 359-359. DOI: 10.1200/Jco.2015.33.7_Suppl.359 |
0.322 |
|
| Show low-probability matches. |
